The present study aims to assess the levels of DPP-4 in serum and saliva of individuals with both lesions to explore its potential as a diagnostic biomarker for early oral cancer detection, distinguishing it from OPMLs and healthy subjects. Here, DPP4 is linked to lip and oral cavity carcinoma.